Dawn Biopharma
2 rounds tracked since 9 October 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $287M
Sectors
Countries
Rounds
- AdcytherixAntibody-drug conjugates for cancer built on novel payloads $122MSeries A · 16 Oct
- Expedition TherapeuticsDeveloping a DPP1 inhibitor for COPD, licensed from Fosun Pharma $165MSeries A · 9 Oct
No round matches these filters.